MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 14.03.2026
QIAGEN N.V. P/S 2011-2026 | QGEN
P/S Jährlich QIAGEN N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 5.03 | 6.11 | 5.33 | 5.8 | 5.42 | 4.81 | 4.13 | 3.96 | 3.99 | 3.97 | 3.27 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.11 | 3.27 | 4.71 |
P/S anderer Aktien in der Diagnostik & Forschung
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
1.07 | $ 9.33 | 0.76 % | $ 622 M |  USA |
 |
DexCom
DXCM
|
5.47 | $ 63.66 | -3.68 % | $ 24.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 15.54 | -5.13 % | $ 470 M | USA |
|
Biodesix
BDSX
|
1.29 | $ 13.97 | -4.32 % | $ 1.81 B | USA |
 |
DarioHealth Corp.
DRIO
|
1.47 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 103.93 | 0.82 % | $ 8.57 B |  Irlanda |
 |
IQVIA Holdings
IQV
|
1.74 | $ 165.44 | -2.34 % | $ 28.4 B | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
11.9 | $ 567.77 | -0.96 % | $ 45.7 B | USA |
 |
Illumina
ILMN
|
3.75 | $ 119.22 | -4.16 % | $ 19 B | USA |
 |
Lantheus Holdings
LNTH
|
3.32 | $ 75.32 | -1.36 % | $ 5.08 B | USA |
 |
Medpace Holdings
MEDP
|
5.12 | $ 457.07 | -2.04 % | $ 13.2 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 238.68 | -2.47 % | $ 25.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.42 | -4.44 % | $ 409 M | USA |
 |
Co-Diagnostics
CODX
|
5.13 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
6.47 | $ 191.42 | -2.41 % | $ 18.8 B | USA |
 |
National Research Corporation
NRC
|
2.29 | $ 17.08 | -1.62 % | $ 382 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
OPKO Health
OPK
|
6.61 | $ 1.13 | -3.85 % | $ 784 M | USA |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 157.42 | -4.67 % | $ 7.8 B | USA |
 |
Organovo Holdings
ONVO
|
21.5 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
1.76 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
3.11 | $ 1.27 | -5.93 % | $ 381 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 4.8 | 4.58 % | $ 2.58 M | USA |
 |
Personalis
PSNL
|
3 | $ 6.66 | -9.02 % | $ 395 M | USA |
 |
PerkinElmer
PKI
|
5.13 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
4.18 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
0.0879 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
2.76 | $ 57.34 | -3.49 % | $ 4.31 B | USA |
 |
Sotera Health Company
SHC
|
4.09 | $ 13.26 | -2.07 % | $ 3.77 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
Soleno Therapeutics
SLNO
|
10.9 | $ 30.09 | -5.48 % | $ 1.53 B | USA |
 |
Thermo Fisher Scientific
TMO
|
4.4 | $ 478.97 | -2.06 % | $ 181 B | USA |
 |
Trinity Biotech plc
TRIB
|
1.47 | $ 0.62 | 1.06 % | $ 61.9 M | Irlanda |